Clinical trial
Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine…
NCT00289406 · SK Chemicals Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00289406 |
|---|---|
| Title | Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension |
| Official title | An 8 Weeks, Multi-Center, Randomized, Double Blinded, Comparative Phase 3 Clinical Trial to Assess the Efficacy and Safety of S-Amlodipine Gentisate Compared to Amlodipine Besylate in Patients With Mild-to-Moderate Hypertension |
| Lead sponsor | SK Chemicals Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | S-amlodipine gentisate, Amlodipine besylate |
| Enrollment | 110 |
| Start date | Jan 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Feb 9, 2006 |
| Last update posted | Mar 6, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: